HEH4 molecules and uses thereof

Details for Australian Patent Application No. 2004308908 (hide)

Owner Amgen Inc.

Inventors Pisegna, Marlese; Simonet, William Scott

Agent Wrays

Pub. Number AU-B-2004308908

PCT Pub. Number WO2005/063292

Priority 60/532,154 22.12.03 US

Filing date 17 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 26 February 2009

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/063292 Priority application(s): WO2005/063292

26 February 2009 Application Accepted

  Published as AU-B-2004308908

25 June 2009 Standard Patent Sealed

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308911-Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration

2004308902-Functional dip tube for cosmetic dispensers